Director at $CARE sells 2,000 shares in insider sale

James W. Haskins, a director at $CARE, recently sold 2,000 shares of the company amounting to $35,680 on July 28, 2025. This transaction equated to selling 3.1% of their shares of this stock class, leaving them with a remaining 61,900 shares of this class of $CARE stock.

The insider trading activity for $CARE reveals that insiders have conducted 6 trades on the open market in the last 6 months. Among these trades, there were 1 purchase and 5 sales. Some notable individuals who participated in recent $CARE trading activities are Kevin S. Bloomfield, who made 3 sales of 7,138 shares totaling $119,265, Jane Ann Davis, EVP and Chief Administrative Officer, who sold 2,500 shares for an estimated $40,986, James W. Haskins, who sold 2,000 shares for around $35,680, and Catharine L. Midkiff, who purchased 200 shares for $3,294.

In terms of hedge fund activity, 54 institutional investors saw changes in their holdings of $CARE stock in the past quarter. Among these investors, 43 reduced their positions. Significant moves observed include AllianceBernstein L.P. removing 199,712 shares (91.8%) from their portfolio worth approximately $3,231,340 in Q1 2025. In contrast, Diversified Trust Co added 134,098 shares (percentage not specified) to their portfolio in Q2 2025, valued at $2,325,259. Furthermore, Fourthstone LLC reduced 107,080 shares (19.4%) in Q1 2025, totaling $1,732,554, while UBS Group AG removed 98,774 shares (72.9%) in Q1 2025, for an estimated $1,598,163. Maltese Capital Management LLC added 87,456 shares (43.5%) during Q1 2025, amounting to $1,415,038. Goldman Sachs Group Inc removed 66,198 shares (24.0%) in Q1 2025, valued at $1,071,083, and Arrowstreet Capital, Limited Partnership subtracted 66,123 shares (60.2%) in Q1 2025, approximately $1,069,870.

It is important to note that this article serves as a disclosure of recent insider trading and hedge fund activity related to $CARE stock and is not intended to provide financial advice. Readers are advised to refer to Quiver Quantitative’s disclaimers for further information regarding this data.